Open access · OA
via Europe PMC
Vascular Phenotyping Across the CKM Syndrome: Arterial Stiffness and Endothelial Function Testing, Prognostic Value and Clinical Implementation.
Gerdanovics CA, Alexescu TG, Login C, Orășan OH, Tiperciuc B, Tomoiagă AV, Ciulei G, Milea PA, Măgureanu DC, Hiceag LM, Andronescu AC, Gerdanovics A, Milaciu MV, Perne MG, Sitar Tăut AV
Diagnostics (Basel, Switzerland) · 2026
Abstract
Cardiovascular-kidney-metabolic (CKM) syndrome represents a continuum of metabolic, renal, and cardiovascular abnormalities in which vascular dysfunction may develop before clinically overt cardiovascular disease. Endothelial dysfunction, arterial stiffness, microvascular abnormalities, and structural vascular damage may therefore provide complementary information regarding vascular injury across CKM stages. This narrative review synthesizes current evidence on the pathophysiological basis, non-invasive assessment, prognostic value, and clinical implementation of vascular phenotyping across the CKM spectrum, with particular emphasis on arterial stiffness and endothelial function. The principal approaches discussed include carotid-femoral pulse wave velocity (cfPWV), brachial-ankle pulse wave velocity, flow-mediated dilation (FMD), peripheral arterial tonometry, microvascular techniques, and structural markers such as coronary artery calcium (CAC) and carotid plaque, considered in the context of contemporary CKM staging and PREVENT-based risk assessment. Among functional vascular measures, cfPWV remains the best-validated non-invasive marker of aortic stiffness and is independently associated with cardiovascular and renal outcomes, whereas FMD provides complementary information on conduit-artery endothelial function but is limited by technical requirements and inconsistent incremental predictive value. Microvascular and glycocalyx-based techniques remain less standardized, while structural phenotyping, particularly CAC and carotid plaque assessment, has stronger evidence for risk reclassification in selected populations. Vascular phenotyping should therefore be regarded as a selective, risk-adapted strategy rather than a universal screening approach. Its greatest potential may lie in integrating vascular measures with CKM stage, PREVENT estimates, kidney and cardiac biomarkers, and structural imaging to identify disproportionate or subclinical vascular injury, particularly during progression from CKM stage 2 to stage 3. Prospective studies are needed to determine whether such multimodal phenotyping improves therapeutic decision-making and cardiovascular and kidney outcomes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.3390/diagnostics16203273
- Canonical
- link ↗
- Fetched
- 2026-10-31 MST
Cite this
APA
CA, G., TG, A., C, L., OH, O., B, T., AV, T., G, C., PA, M., DC, M., LM, H., AC, A., A, G., MV, M., MG, P., AV, S.T., & A., C. (2026). Vascular Phenotyping Across the CKM Syndrome: Arterial Stiffness and Endothelial Function Testing, Prognostic Value and Clinical Implementation. <em>Diagnostics (Basel, Switzerland)</em>. https://doi.org/10.3390/diagnostics16203273
Vancouver
CA G, TG A, C L, OH O, B T, AV T, et al. Vascular Phenotyping Across the CKM Syndrome: Arterial Stiffness and Endothelial Function Testing, Prognostic Value and Clinical Implementation. Diagnostics (Basel, Switzerland). 2026. doi:10.3390/diagnostics16203273.
BibTeX
@article{gerdanovics2026Vascul,
title = {Vascular Phenotyping Across the CKM Syndrome: Arterial Stiffness and Endothelial Function Testing, Prognostic Value and Clinical Implementation.},
author = {Gerdanovics CA and Alexescu TG and Login C and Orășan OH and Tiperciuc B and Tomoiagă AV and Ciulei G and Milea PA and Măgureanu DC and Hiceag LM and Andronescu AC and Gerdanovics A and Milaciu MV and Perne MG and Sitar Tăut AV and Cozma A.},
journal = {Diagnostics (Basel, Switzerland)},
year = {2026},
doi = {10.3390/diagnostics16203273},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Diagnostics (Basel, Switzerland) 2026
Open access · OA
Vascular Phenotyping Across the CKM Syndrome: Arterial Stiffness and Endothelial Function Testing, Prognostic Value and Clinical Implementation
Figshare 2022
Preprint · CC-BY
Vascular Aging and Arterial Stiffness
Current Issues in Molecular Biology 2026
Open access · CC-BY
Helicobacter pylori and Early Vascular Aging: Endothelial Dysfunction, Arterial Stiffness, and Conditional Cardiovascular Vulnerability
Current issues in molecular biology 2026
Open access · OA
<i>Helicobacter pylori</i> and Early Vascular Aging: Endothelial Dysfunction, Arterial Stiffness, and Conditional Cardiovascular Vulnerability.
Ageing research reviews 2026
Citation only
Biomarkers and therapies Associated with Hutchinson-Gilford Syndrome.
Biomolecules 2026
Open access · OA